Human umbilical cord blood-mesenchymal stem cell derived exosomes as an efficient nanocarrier for Docetaxel and miR-125a: Formulation optimization and anti-metastatic behaviour DOI
Moumita Basak, Biswajit Sahoo,

Dharmendra Kumar Chaudhary

и другие.

Life Sciences, Год журнала: 2023, Номер 322, С. 121621 - 121621

Опубликована: Март 30, 2023

Язык: Английский

Therapeutically harnessing extracellular vesicles DOI
Lesley Cheng, Andrew F. Hill

Nature Reviews Drug Discovery, Год журнала: 2022, Номер 21(5), С. 379 - 399

Опубликована: Март 2, 2022

Язык: Английский

Процитировано

492

Intradermally delivered mRNA-encapsulating extracellular vesicles for collagen-replacement therapy DOI Open Access

Yi You,

Yu Tian, Zhaogang Yang

и другие.

Nature Biomedical Engineering, Год журнала: 2023, Номер 7(7), С. 887 - 900

Опубликована: Янв. 12, 2023

Язык: Английский

Процитировано

126

Therapeutic Properties of Mesenchymal Stromal/Stem Cells: The Need of Cell Priming for Cell-Free Therapies in Regenerative Medicine DOI Open Access
Vitale Miceli, Matteo Bulati, Gioacchin Iannolo

и другие.

International Journal of Molecular Sciences, Год журнала: 2021, Номер 22(2), С. 763 - 763

Опубликована: Янв. 14, 2021

Mesenchymal stromal/stem cells (MSCs) are multipotent adult stem that support homeostasis during tissue regeneration. In the last decade, cell therapies based on use of MSCs have emerged as a promising strategy in field regenerative medicine. Although these possess robust therapeutic properties can be applied treatment different diseases, variables preclinical and clinical trials lead to inconsistent outcomes. MSC effects result from secretion bioactive molecules affected by either local microenvironment or culture conditions. Hence, paracrine action is currently being explored several settings using conditioned medium (CM) MSC-derived exosomes (EXOs), where products modulate responses types injuries. this scenario, mechanisms provide framework for enhancing benefits, composition secretome modulated priming MSCs. review, we examine literature tool enhance their applicable main processes involved regeneration, including reduction fibrosis, immunomodulation, stimulation angiogenesis, resident progenitor cells, thereby providing new insights MSCs-derived products.

Язык: Английский

Процитировано

121

Stem cell-derived exosomes: emerging therapeutic opportunities for wound healing DOI Creative Commons
Chuchao Zhou, Boyu Zhang, Yanqing Yang

и другие.

Stem Cell Research & Therapy, Год журнала: 2023, Номер 14(1)

Опубликована: Апрель 26, 2023

Abstract Wound healing is a dynamic and highly sequential process involving series of overlapping spatial temporal phases, including hemostasis, inflammation, proliferation, tissue remodeling. Mesenchymal stem cells (MSCs) are multipotent with self-renewal, multidirectional differentiation potential, paracrine regulation. Exosomes subcellular vesicular components 30–150 nm in size novel carriers intercellular communication regulating the biological behaviors skin cells. Compared to MSCs, MSC-derived exosomes (MSC-exos) possess lower immunogenicity, easy storage, effective activity. MSC-exos, mainly derived from adipose-derived (ADSCs), bone marrow-derived MSCs (BMSCs), human umbilical cord (hUC-MSCs), other cell types, play role shaping activity fibroblasts, keratinocytes, immune cells, endothelial diabetic wounds, inflammatory wound repair, even wound-related keloid formation. Therefore, this study focuses on specific roles mechanisms different MSC-exos healing, as well current limitations various perspectives. Deciphering properties crucial providing promising cell-free therapeutic tool for cutaneous regeneration. Graphical

Язык: Английский

Процитировано

120

Emerging mechanisms of obesity-associated immune dysfunction DOI
Saame Raza Shaikh, Melinda A. Beck,

Yazan Alwarawrah

и другие.

Nature Reviews Endocrinology, Год журнала: 2023, Номер 20(3), С. 136 - 148

Опубликована: Дек. 21, 2023

Язык: Английский

Процитировано

54

Understanding exosomes: Part 2—Emerging leaders in regenerative medicine DOI Creative Commons
Richard J. Miron, Nathan E. Estrin, Anton Sculean

и другие.

Periodontology 2000, Год журнала: 2024, Номер 94(1), С. 257 - 414

Опубликована: Фев. 1, 2024

Abstract Exosomes are the smallest subset of extracellular signaling vesicles secreted by most cells with ability to communicate other tissues and cell types over long distances. Their use in regenerative medicine has gained tremendous momentum recently due their be utilized as therapeutic options for a wide array diseases/conditions. Over 5000 publications currently being published yearly on this topic, number is only expected dramatically increase novel strategies continue developed. Today exosomes have been applied numerous contexts including neurodegenerative disorders (Alzheimer's disease, central nervous system, depression, multiple sclerosis, Parkinson's post‐traumatic stress disorders, traumatic brain injury, peripheral nerve injury), damaged organs (heart, kidney, liver, stroke, myocardial infarctions, ovaries), degenerative processes (atherosclerosis, diabetes, hematology musculoskeletal degeneration, osteoradionecrosis, respiratory disease), infectious diseases (COVID‐19, hepatitis), procedures (antiaging, bone regeneration, cartilage/joint osteoarthritis, cutaneous wounds, dental dermatology/skin erectile dysfunction, hair regrowth, intervertebral disc repair, spinal cord vascular regeneration), cancer therapy (breast, colorectal, gastric osteosarcomas), immune function (allergy, autoimmune regulation, inflammatory diseases, lupus, rheumatoid arthritis). This scoping review first its kind aimed at summarizing extensive potential broad range disorders.

Язык: Английский

Процитировано

16

Exosomes as Drug Delivery Systems: Endogenous Nanovehicles for Treatment of Systemic Lupus Erythematosus DOI Creative Commons
Ana Ortega, Olga Martínez-Arroyo, María José Forner

и другие.

Pharmaceutics, Год журнала: 2020, Номер 13(1), С. 3 - 3

Опубликована: Дек. 22, 2020

Exosomes, nanometer-sized lipid-bilayer-enclosed extracellular vesicles (EVs), have attracted increasing attention due to their inherent ability shuttle proteins, lipids and genes between cells natural affinity target cells. Their intrinsic features such as stability, biocompatibility, low immunogenicity overcome biological barriers, prompted interest in using exosomes drug delivery vehicles, especially for gene therapy. Evidence indicates that play roles both immune stimulation tolerance, regulating signaling inflammation. To date, exosome-based nanocarriers delivering small molecule drugs been developed treat many prevalent autoimmune diseases. This review highlights the key of therapeutic cargo, use targeting peptide, loading method administration route with a broad focus. In addition, we outline current state evidence field systems systemic lupus erythematosus (SLE), evaluating derived from various cell types engineered exosomes.

Язык: Английский

Процитировано

73

Antibacterial, adhesive, and MSC exosomes encapsulated microneedles with spatio-temporal variation functions for diabetic wound healing DOI
Jingjing Gan, Xiaoxuan Zhang, Wenjuan Ma

и другие.

Nano Today, Год журнала: 2022, Номер 47, С. 101630 - 101630

Опубликована: Окт. 3, 2022

Язык: Английский

Процитировано

67

Breakthrough of extracellular vesicles in pathogenesis, diagnosis and treatment of osteoarthritis DOI Creative Commons
Zichang Liu, Yu Zhuang,

Lianfei Fang

и другие.

Bioactive Materials, Год журнала: 2022, Номер 22, С. 423 - 452

Опубликована: Окт. 20, 2022

Osteoarthritis (OA) is a highly prevalent whole-joint disease that causes disability and pain affects patient's quality of life. However, currently, there lack effective early diagnosis treatment. Although stem cells can promote cartilage repair treat OA, problems such as immune rejection tumorigenicity persist. Extracellular vesicles (EVs) transmit genetic information from donor mediate intercellular communication, which considered functional paracrine factor cells. Increasing evidences suggest EVs may play an essential complex role in the pathogenesis, diagnosis, treatment OA. Here, we introduced OA progression by influencing inflammation, metabolism, aging. Next, discussed blood, synovial fluid, joint-related for diagnosis. Moreover, outlined potential modified unmodified their combination with biomaterials therapy. Finally, discuss deficiencies put forward prospects challenges related to application field

Язык: Английский

Процитировано

60

Extracellular vesicles in cancer therapy DOI Creative Commons
Shizhen Emily Wang

Seminars in Cancer Biology, Год журнала: 2022, Номер 86, С. 296 - 309

Опубликована: Июнь 8, 2022

Язык: Английский

Процитировано

44